Pharnext: AGM in sight, plan to convert into an SCA
The biopharmaceutical company plans to hold a combined ordinary and extraordinary shareholders' meeting on February 24 at Néovacs' headquarters.
Shareholders will be asked to vote on a new legal structure, with the transformation of the company from a société anonyme into a société en commandite par action (S.C.A.).
In terms of governance, Néovacs (represented by Hugo Brugière, CEO of Néovacs and current CEO of Pharnext) would become Chairman of Pharnext Développement, which would in turn become managing director of Pharnext.
The Supervisory Board of Pharnext, incorporated as an S.C.A., would be made up of the current members of the Board of Directors: Joshua Schafer, Lawrence Steinman and James Kuo.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction